Late-stage biotech company developing potentially curative gene therapies through leveraging its proprietary NAV technology (consists of novel AAV vectors) Generates significant revenue through … [Read more...] about Regenxbio (RGNX)-About
stocks
GTHX Commercial Update 12/16/21-Transcript
Operator 0:10 Ladies and gentlemen, thank you for standing by and welcome to the G1 commercial update. At this time all participants are in listen only mode. After the speaker's presentation … [Read more...] about GTHX Commercial Update 12/16/21-Transcript
Gene Therapy Exciting, But Early
Gene therapy involves inserting genetic material into cells to prevent, cure, or correct a disease caused by genetic abnormalities whereas gene editing involves making actual changes to the genetic … [Read more...] about Gene Therapy Exciting, But Early
GNMK Coverage Update
GenMark Diagnostics (Nasdaq: GNMK) Coverage Update 2/7/21 Outlook: Bullish PT = $20 (0-24 weeks) About GNMKÂ A commercial-stage medical-diagnostic company marketing its proprietary eSensor … [Read more...] about GNMK Coverage Update
Daily Trade Insights
ChemoCentryx Inc Trade Idea
Trade Summary Ticker: CCXI (Last: $8.84) Entry: $8.50-8.84 Price Target: $13-15.0+ Target Timeframe: 0-6 weeks Trade ThesisCCXI is an orphan/rare disease-focused company with … [Read more...] about ChemoCentryx Inc Trade Idea
Incoming Data + Gartley
Friday, October 11, 2019 About: ADVERUM BIOTECHNOLOGIES INC (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, ADVM is set … [Read more...] about Incoming Data + Gartley
Trade-Ideas for Monday, August 12th, 2019
Trade-Ideas: Thursday, Monday, August 12th, 2019Trade ideas for next week:1) BDSI $4.36* Continuation swing opportunity.* Gained 16% last week.* Released strong earnings last week with strong revenue … [Read more...] about Trade-Ideas for Monday, August 12th, 2019
Foamix Pharmaceuticals: A dermatology play with more than 100% upside potential
Foamix Pharmaceuticals (NASDAQ: FOMX) shares have been on a free fall for the past six months, declining by more than 30 percent to $2.3. The clinical-stage company which develops and commercializes … [Read more...] about Foamix Pharmaceuticals: A dermatology play with more than 100% upside potential
Immunomedics’ Risk vs. Reward
Press play on chart to watch IMMU trade in real-time. #IMMU look at Risk vs. Reward #Volatilitywatch by follow_the_money on TradingView.com Immunomedics Inc. (Nasdaq: IMMU) brings … [Read more...] about Immunomedics’ Risk vs. Reward
You must be logged in to post a comment.